Searched for
INSULIN SENSITISER
- DRL’s anti-diabetes drug to hit market by ’11
Dr Reddy’s anti-diabetes molecule Balaglitazone, which has entered the final phase of clinical development, is expected to hit the world ma...
16 Nov, 2007, 02.51 AM IST
- How Dr Reddy's chased diabetes molecule dream
Dr Reddy’s pursuit of past 13 years for the type 2 diabetes molecule is in its last lap, with the product entering the final phase of clini...
09 Aug, 2007, 05.45 AM IST
- Foreign players look at India to develop lower-cost drugs
German pharma major Boehringer Ingelheim is close to completing its first in-licensing deal with an Indian pharmaceutical company.
23 May, 2007, 12.18 AM IST
- Wanted, MNC allies
New drug discoveries are the pharmaceutical equivalent of an alchemist’s search for a magic formula to turn base metals into gold.
12 Sep, 2006, 01.55 AM IST